Home Other Building Blocks 253863-19-3
253863-19-3,MFCD12912700
Catalog No.:AA00BE8E

253863-19-3 | LL Z1640-2

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥99%
in stock  
$123.00   $86.00
- +
5mg
≥99%
in stock  
$428.00   $299.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00BE8E
Chemical Name:
LL Z1640-2
CAS Number:
253863-19-3
Molecular Formula:
C19H22O7
Molecular Weight:
362.3738
MDL Number:
MFCD12912700
SMILES:
COc1cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@@H](OC(=O)c2c(c1)O)C
Properties
Computed Properties
 
Complexity:
556  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
2  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
1  
XLogP3:
2.6  

Literature

Title: Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships.

Journal: Journal of natural products 20110527

Title: Total synthesis of TAK-kinase inhibitor LL-Z1640-2 via consecutive macrocyclization and transannular aromatization.

Journal: Organic letters 20101203

Title: Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III.

Journal: Bioorganic & medicinal chemistry letters 20100515

Title: Conformational analyses and MO studies of f152A1 and its analogues as potent protein kinase inhibitors.

Journal: Journal of chemical information and modeling 20091201

Title: Divergent syntheses of resorcylic acid lactones: L-783277, LL-Z1640-2, and hypothemycin.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20091102

Title: E6201 [(3S,4R,5Z,8S,9S,11E)-14-(ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1 and MEK kinase-1: in vitro characterization of its anti-inflammatory and antihyperproliferative activities.

Journal: The Journal of pharmacology and experimental therapeutics 20091101

Title: Role of a cysteine residue in the active site of ERK and the MAPKK family.

Journal: Biochemical and biophysical research communications 20070216

Title: Chemistry and biology of resorcylic acid lactones.

Journal: Chemical communications (Cambridge, England) 20070107

Title: Suppression of cadmium-induced JNK/p38 activation and HSP70 family gene expression by LL-Z1640-2 in NIH3T3 cells.

Journal: Toxicology and applied pharmacology 20040415

Title: Ninomiya-Tsuji J, et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem. 2003 May 16;278(20):18485-90.

Title: Dakas PY, et al. Modular synthesis of radicicol A and related resorcylic acid lactones, potent kinase inhibitors. Angew Chem Int Ed Engl. 2007;46(36):6899-902.

Title: Takehana K, et al. A radicicol-related macrocyclic nonaketide compound, antibiotic LL-Z1640-2, inhibits the JNK/p38 pathways in signal-specific manner. Biochem Biophys Res Commun. 1999 Apr 2;257(1):19-23.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 253863-19-3
Tags:253863-19-3 Molecular Formula|253863-19-3 MDL|253863-19-3 SMILES|253863-19-3 LL Z1640-2